MyAverix Finance
SHG · Healthcare
Novogene Co. Ltd. (688315)
Biotechnology
Novogene Co. Ltd. (688315) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $5.74B, P/E ratio is 32.07, net margin is 8.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688315
Novogene Co. Ltd. (688315) — FAQ
What is Novogene Co. Ltd.'s market cap?
Novogene Co. Ltd. (688315) has a reported market cap of $5.74B (data as of 2026-03-29).
What is 688315's P/E ratio?
The price-to-earnings (P/E) ratio for Novogene Co. Ltd. (688315) is 32.07 (data as of 2026-03-29).
Does Novogene Co. Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Novogene Co. Ltd. (688315). Check the MyAverix Finance app for the latest dividend data.
What sector is Novogene Co. Ltd. in?
Novogene Co. Ltd. (688315) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688315 listed on?
688315 is listed on SHG.
What is Novogene Co. Ltd.'s net margin?
Novogene Co. Ltd. (688315) reports a net margin of 8.1% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.